SARS-CoV-2 Delta Variant Pathogenesis and Host Response in Syrian Hamsters

B.1.617 is becoming a dominant Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) lineage worldwide with many sublineages, of which B.1.617.2 is designated as a variant of concern. The pathogenicity of B.1.617.2 (Delta) and B.1.617.3 lineage of SARS-CoV-2 was evaluated and compared with th...

Full description

Bibliographic Details
Published in:	Viruses
Main Authors:	Sreelekshmy Mohandas, Pragya Dhruv Yadav, Anita Shete, Dimpal Nyayanit, Gajanan Sapkal, Kavita Lole, Nivedita Gupta
Format:	Article
Language:	English
Published:	MDPI AG 2021-09-01
Subjects:	SARS-CoV-2 Delta variant B.1.617.2 B.1.617.3 Syrian hamster pathogenicity
Online Access:	https://www.mdpi.com/1999-4915/13/9/1773

Similar Items

Protective Immunity of the Primary SARS-CoV-2 Infection Reduces Disease Severity Post Re-Infection with Delta Variants in Syrian Hamsters
by: Sreelekshmy Mohandas, et al.
Published: (2022-03-01)

Analysis of the Delta Variant B.1.617.2 COVID-19
by: Shayan Shiehzadegan, et al.
Published: (2021-10-01)

Antibody-Mediated Neutralization of Authentic SARS-CoV-2 B.1.617 Variants Harboring L452R and T478K/E484Q
by: Alexander Wilhelm, et al.
Published: (2021-08-01)

Clinical features and high-resolution chest computerized tomography findings of children infected by the B.1.617.2 variant of coronavirus disease 2019
by: Chuanjun Xu, et al.
Published: (2022-12-01)

Heterologous ChAdOx1 nCoV-19 and BNT162b2 prime-boost vaccination elicits potent neutralizing antibody responses and T cell reactivity against prevalent SARS-CoV-2 variants
by: Rüdiger Groß, et al.
Published: (2022-01-01)

D-dimers in omicron versus delta: A retrospective analysis
by: Alon H. Shulman, et al.
Published: (2022-11-01)

Vaccination Decreases the Infectious Viral Load of Delta Variant SARS-CoV-2 in Asymptomatic Patients
by: Jessica A. Plante, et al.
Published: (2022-09-01)

Pathogenicity of SARS-CoV-2 Omicron (R346K) variant in Syrian hamsters and its cross-neutralization with different variants of concern
by: Sreelekshmy Mohandas, et al.
Published: (2022-05-01)

Assessing the Transmissibility of the New SARS-CoV-2 Variants: From Delta to Omicron
by: Rui Dong, et al.
Published: (2022-03-01)

Genome Analysis of SARS-CoV-2 Delta variant in the Kurdistan region of Iraq
by: Sevan O Majed, et al.
Published: (2024-11-01)

Neutralization of SARS-CoV-2 Variants by Serum from BNT162b2 Vaccine Recipients
by: Fabrizia Valleriani, et al.
Published: (2021-10-01)

SARS CoV-2 (Delta Variant) Infection Kinetics and Immunopathogenesis in Domestic Cats
by: Miruthula Tamil Selvan, et al.
Published: (2022-06-01)

Impact of SARS-CoV-2 delta variant (B.1.617.2) in surging second wave of COVID-19 and efficacy of vaccines in tackling the ongoing pandemic
by: Abu Montakim Tareq, et al.
Published: (2021-11-01)

Emergence and Spread of the SARS-CoV-2 Variant of Concern Delta across Different Brazilian Regions
by: Ighor Arantes, et al.
Published: (2022-10-01)

Characterization of Three Variants of SARS-CoV-2 In Vivo Shows Host-Dependent Pathogenicity in Hamsters, While Not in K18-hACE2 Mice
by: Gabriela Toomer, et al.
Published: (2022-11-01)

First Detection of SARS-CoV-2 Delta (B.1.617.2) Variant of Concern in a Dog with Clinical Signs in Spain
by: Leira Fernández-Bastit, et al.
Published: (2021-12-01)

Methylene Blue Is a Nonspecific Protein–Protein Interaction Inhibitor with Potential for Repurposing as an Antiviral for COVID-19
by: Sung-Ting Chuang, et al.
Published: (2022-05-01)

Monoclonal Antibody Therapy in a Vaccine Breakthrough SARS-CoV-2 Hospitalized Delta (B.1.617.2) Variant Case
by: Bradley A Connor, et al.
Published: (2021-09-01)

BNT162b2 Booster Vaccination Induced Immunity against SARS-CoV-2 Variants among Hemodialysis Patients
by: Michal Herman-Edelstein, et al.
Published: (2022-06-01)

Effectiveness of COVID-19 Vaccines against Delta Variant (B.1.617.2): A Meta-Analysis
by: Rashidul Alam Mahumud, et al.
Published: (2022-02-01)

Airborne Transmission of the SARS-CoV-2 Delta Variant and the SARS-CoV-2 Omicron Variant
by: Byung Uk Lee
Published: (2021-12-01)

Comparative Sensitivity of Rapid Antigen Tests for the Delta Variant (B.1.617.2) of SARS-CoV-2
by: Yuko Sakai-Tagawa, et al.
Published: (2021-10-01)

A computational evaluation of structural stability of omicron and delta mutations of SARS-CoV-2 spike proteins and human ACE-2 interactions
by: Kehinde A. Idowu, et al.
Published: (2022-01-01)

Early introduction, dispersal and evolution of Delta SARS-CoV-2 in Southern Brazil, late predominance of AY.99.2 and AY.101 related lineages
by: Juliana Schons Gularte, et al.
Published: (2022-04-01)

In Silico Analysis of SARS-CoV-2 Spike Proteins of Different Field Variants
by: Muhammad Haseeb, et al.
Published: (2023-03-01)

Effects of Casirivimab/Imdevimab Monoclonal Antibody Treatment among Vaccinated Patients Infected by SARS-CoV-2 Delta Variant
by: Gaetano Cicchitto, et al.
Published: (2022-03-01)

Mental health and chest CT scores mediate the relationship between COVID-19 vaccination status and seroconversion time: A cross-sectional observational study in B.1.617.2 (Delta) infection patients
by: Wen Zhang, et al.
Published: (2022-10-01)

Better binding informatics of delta variants (B.1.617.2) with ACE2 than wild, D614G or N501Y CoV-2 is fully blocked by 84 amino-acid cut of wild spike
by: Dipannita Santra, et al.
Published: (2022-01-01)

Broad-Spectrum Small-Molecule Inhibitors of the SARS-CoV-2 Spike—ACE2 Protein–Protein Interaction from a Chemical Space of Privileged Protein Binders
by: Sung-Ting Chuang, et al.
Published: (2022-08-01)

Evolution of neutralizing antibodies and cross-activity against different variants of SARS-CoV-2 in patients recovering from COVID-19
by: Wang-Da Liu, et al.
Published: (2023-08-01)

Higher mortality associated with the SARS-CoV-2 Delta variant in the Western Cape, South Africa, using RdRp target delay as a proxy: a cross-sectional study. [version 1; peer review: 2 approved]
by: Hannah Hussey, et al.
Published: (2022-08-01)

Comparative Evolutionary Epidemiology of SARS-CoV-2 Delta and Omicron Variants in Kuwait
by: Moh A. Alkhamis, et al.
Published: (2024-11-01)

Outbreak of SARS-CoV-2 variants in Iraqi Kurdistan region
by: Sevan O Majed, et al.
Published: (2024-09-01)

Longitudinal analysis of SARS-CoV-2 reinfection reveals distinct kinetics and emergence of cross-neutralizing antibodies to variants of concern
by: Antonio Facciuolo, et al.
Published: (2023-03-01)

Isolation and Genomic Characterization of SARS-CoV-2 Omicron Variant Obtained from Human Clinical Specimens
by: Pragya D. Yadav, et al.
Published: (2022-02-01)

Comparison of the analytical and clinical sensitivities of 34 rapid antigen tests with prevalent SARS-CoV-2 variants of concern during the COVID-19 pandemic in the UK
by: Rachel L. Byrne, et al.
Published: (2025-10-01)

Dynamic characteristics of a COVID-19 outbreak in Nanjing, Jiangsu province, China
by: Junjun Wang, et al.
Published: (2022-11-01)

Breakthrough infection with SARS-CoV-2 delta variant in old-age homes in a Southern District of Kerala, India
by: Dhanusha Chandran, et al.
Published: (2022-01-01)

Virus-Specific Stem Cell Memory CD8+ T Cells May Indicate a Long-Term Protection against Evolving SARS-CoV-2
by: Milena Aleksova, et al.
Published: (2023-03-01)

Fast forward evolution in real time: the rapid spread of SARS-CoV-2 variant of concern lineage B.1.1.7 in Saxony-Anhalt over a period of 5 months
by: Glaß Markus, et al.
Published: (2022-02-01)